213 related articles for article (PubMed ID: 33385746)
1. Microfluidic chip for graduated magnetic separation of circulating tumor cells by their epithelial cell adhesion molecule expression and magnetic nanoparticle binding.
Williams PS; Moore LR; Joshi P; Goodin M; Zborowski M; Fleischman A
J Chromatogr A; 2021 Jan; 1637():461823. PubMed ID: 33385746
[TBL] [Abstract][Full Text] [Related]
2. Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.
Chen W; Allen SG; Reka AK; Qian W; Han S; Zhao J; Bao L; Keshamouni VG; Merajver SD; Fu J
BMC Cancer; 2016 Aug; 16():614. PubMed ID: 27501846
[TBL] [Abstract][Full Text] [Related]
3. Selective isolation of magnetic nanoparticle-mediated heterogeneity subpopulation of circulating tumor cells using magnetic gradient based microfluidic system.
Kwak B; Lee J; Lee D; Lee K; Kwon O; Kang S; Kim Y
Biosens Bioelectron; 2017 Feb; 88():153-158. PubMed ID: 27503409
[TBL] [Abstract][Full Text] [Related]
4. Spiral shape microfluidic channel for selective isolating of heterogenic circulating tumor cells.
Kwak B; Lee J; Lee J; Kim HS; Kang S; Lee Y
Biosens Bioelectron; 2018 Mar; 101():311-316. PubMed ID: 29055574
[TBL] [Abstract][Full Text] [Related]
5. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
[TBL] [Abstract][Full Text] [Related]
6. Two-stage microfluidic chip for selective isolation of circulating tumor cells (CTCs).
Hyun KA; Lee TY; Lee SH; Jung HI
Biosens Bioelectron; 2015 May; 67():86-92. PubMed ID: 25060749
[TBL] [Abstract][Full Text] [Related]
7. A PLGA nanofiber microfluidic device for highly efficient isolation and release of different phenotypic circulating tumor cells based on dual aptamers.
Wu Z; Pan Y; Wang Z; Ding P; Gao T; Li Q; Hu M; Zhu W; Pei R
J Mater Chem B; 2021 Mar; 9(9):2212-2220. PubMed ID: 33616137
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of circulating tumor cells detected with the microfluidic "universal CTC-chip" for primary lung cancer.
Kanayama M; Kuwata T; Mori M; Nemoto Y; Nishizawa N; Oyama R; Matsumiya H; Taira A; Shinohara S; Takenaka M; Yoneda K; Kuroda K; Ohnaga T; Tanaka F
Cancer Sci; 2022 Mar; 113(3):1028-1037. PubMed ID: 34964211
[TBL] [Abstract][Full Text] [Related]
9. Molecular Profiling of Pooled Circulating Tumor Cells from Prostate Cancer Patients Using a Dual-Antibody-Functionalized Microfluidic Device.
Yin C; Wang Y; Ji J; Cai B; Chen H; Yang Z; Wang K; Luo C; Zhang W; Yuan C; Wang F
Anal Chem; 2018 Mar; 90(6):3744-3751. PubMed ID: 29464943
[TBL] [Abstract][Full Text] [Related]
10. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip.
Sheng W; Ogunwobi OO; Chen T; Zhang J; George TJ; Liu C; Fan ZH
Lab Chip; 2014 Jan; 14(1):89-98. PubMed ID: 24220648
[TBL] [Abstract][Full Text] [Related]
11. A chip assisted immunomagnetic separation system for the efficient capture and in situ identification of circulating tumor cells.
Tang M; Wen CY; Wu LL; Hong SL; Hu J; Xu CM; Pang DW; Zhang ZL
Lab Chip; 2016 Apr; 16(7):1214-23. PubMed ID: 26928405
[TBL] [Abstract][Full Text] [Related]
12. Highly efficient capture and harvest of circulating tumor cells on a microfluidic chip integrated with herringbone and micropost arrays.
Xue P; Wu Y; Guo J; Kang Y
Biomed Microdevices; 2015 Apr; 17(2):39. PubMed ID: 25749640
[TBL] [Abstract][Full Text] [Related]
13. A microfluidic device for enhanced capture and high activity release of heterogeneous CTCs from whole blood.
Li Q; Wang Y; Gao W; Qian G; Chen X; Liu Y; Yu S
Talanta; 2024 Jan; 266(Pt 1):125007. PubMed ID: 37556952
[TBL] [Abstract][Full Text] [Related]
14. Combination of antibody-coated, physical-based microfluidic chip with wave-shaped arrays for isolating circulating tumor cells.
Chen H; Cao B; Chen H; Lin YS; Zhang J
Biomed Microdevices; 2017 Sep; 19(3):66. PubMed ID: 28776234
[TBL] [Abstract][Full Text] [Related]
15. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.
Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA
N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682
[TBL] [Abstract][Full Text] [Related]
16. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer.
Hyun KA; Koo GB; Han H; Sohn J; Choi W; Kim SI; Jung HI; Kim YS
Oncotarget; 2016 Apr; 7(17):24677-87. PubMed ID: 27013581
[TBL] [Abstract][Full Text] [Related]
18. Single-Cell Phenotypic Profiling of CTCs in Whole Blood Using an Integrated Microfluidic Device.
Pei H; Li L; Wang Y; Sheng R; Wang Y; Xie S; Shui L; Si H; Tang B
Anal Chem; 2019 Sep; 91(17):11078-11084. PubMed ID: 31373191
[TBL] [Abstract][Full Text] [Related]
19. Microfluidic Devices for Circulating Tumor Cells Isolation and Subsequent Analysis.
Khamenehfar A; Li PC
Curr Pharm Biotechnol; 2016; 17(9):810-21. PubMed ID: 26927214
[TBL] [Abstract][Full Text] [Related]
20. A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells.
Hvichia GE; Parveen Z; Wagner C; Janning M; Quidde J; Stein A; Müller V; Loges S; Neves RP; Stoecklein NH; Wikman H; Riethdorf S; Pantel K; Gorges TM
Int J Cancer; 2016 Jun; 138(12):2894-904. PubMed ID: 26789903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
